Cetirizine dihydrochloride
CAS No. 83881-52-1
Cetirizine dihydrochloride ( P-071 )
Catalog No. M16110 CAS No. 83881-52-1
A second-generation antihistamine that acts as a selective H1 receptor antagonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
50MG | 32 | In Stock |
|
100MG | 45 | In Stock |
|
200MG | 65 | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCetirizine dihydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionA second-generation antihistamine that acts as a selective H1 receptor antagonist.
-
DescriptionA second-generation antihistamine that acts as a selective H1 receptor antagonist; used in the treatment of allergies.Allergy Approved
-
SynonymsP-071
-
PathwayGPCR/G Protein
-
TargetHistamine Receptor
-
RecptorH1receptor
-
Research AreaInflammation/Immunology
-
IndicationAllergy
Chemical Information
-
CAS Number83881-52-1
-
Formula Weight461.81
-
Molecular FormulaC21H27Cl3N2O3
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESCl.OC(=O)COCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1
-
Chemical NameAcetic acid, 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]-, hydrochloride (1:2)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Propionyl-L-carnitin...
Levocarnitine propionate hcl is used to treat the deterioration of renal function, congestive heart failure, intermittent claudication, and other diseases.
-
GSK-239512
GSK-239512 is an antagonist of H3 receptor and can be used in studies about the treatment of cognitive dysfunction in neurodegenerative disorders.
-
PF-03654764
PF-03654764 (PF 3654764) is a potent, selective, orally bioactive antagonist of H3 receptor with Ki of 1.4 nM.